Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies

Open access
Bueno, H., Betriu, A., Heras, M., Alonso, J. J., Cequier, A., Garcia, E. J., Lopez-Sendon, J. L., Macaya, C., Hernandez-Antolin, R., on behalf of the TRIANA Investigators, Bueno, H., Hernandez-Antolin, R., Alonso, J. J., Betriu, A., Cequier, A., Garcia, E. J., Heras, M., Lopez-Sendon, J. L., Macaya, C., Azpitarte, J., Sanz, G., Chamorro, A., Lopez-Palop, R., Sionis, A., Aros, F., Garcia-Fernandez, E., Rubio, R., Hernandez, F., Tascon, J. C., Moreu, J., Betriu, A., Heras, M., Hernandez-Antolin, R., Fernandez-Ortiz, A., Moris, C., de Posada, I. S., Cequier, A., Esplugas, E., Melgares, R., Bosa, F., Garcia-Gonzalez, M. J., Lezaun, R., Carmona, J. R., Vazquez, J. M., Castro-Beiras, A., Picart, J. G., de Rozas, J. D., Fernandez, J. D., Vazquez, F. F., Alonso, N., Zueco, J. J., San Jose, J. M., San Roman, A., Hernandez, C., Garcia, J. M. H., Alcantara, A. G., Bethencourt, A., Fiol, M., Mancisidor, X., Mancisidor, X., Ruiz, R., Hidalgo, R., Sobrino, N., Maqueda, I. G., Torres, A., Aros, F., Amaro, A., Jaquet, M. · 2011 · European Heart Journal

Abstract

AIMS: To compare primary percutaneous coronary intervention (pPCI) and fibrinolysis in very old patients with ST-segment elevation myocardial infarction (STEMI), in whom head-to-head comparisons between both strategies are scarce. METHODS AND RESULTS: Patients ≥75 years old with STEMI <6 h were randomized to pPCI or fibrinolysis. The primary endpoint was a composite of all-cause mortality, re-infarction, or disabling stroke at 30 days. The trial was prematurely stopped due to slow recruitment after enrolling 266 patients (134 allocated to pPCI and 132 to fibrinolysis). Both groups were well balanced in baseline characteristics. Mean age was 81 years. The primary endpoint was reached in 25 patients in the pPCI group (18.9%) and 34 (25.4%) in the fibrinolysis arm [odds ratio (OR), 0.69; 95% confidence interval (CI) 0.38-1.23; P = 0.21]. Similarly, non-significant reductions were found in death (13.6 vs. 17.2%, P = 0.43), re-infarction (5.3 vs. 8.2%, P = 0.35), or disabling stroke (0.8 vs. 3.0%, P = 0.18). Recurrent ischaemia was less common in pPCI-treated patients (0.8 vs. 9.7%, P< 0.001). No differences were found in major bleeds. A pooled analysis with the two previous reperfusion trials performed in older patients showed an advantage of pPCI over fibrinolysis in reducing death, re-infarction, or stroke at 30 days (OR, 0.64; 95% CI 0.45-0.91). CONCLUSION: Primary PCI seems to be the best reperfusion therapy for STEMI even for the oldest patients. Early contemporary fibrinolytic therapy may be a safe alternative to pPCI in the elderly when this is not available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehq375

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 184

Metadata

Authors
Bueno, H., Betriu, A., Heras, M., Alonso, J. J., Cequier, A., Garcia, E. J., Lopez-Sendon, J. L., Macaya, C., Hernandez-Antolin, R., on behalf of the TRIANA Investigators, Bueno, H., Hernandez-Antolin, R., Alonso, J. J., Betriu, A., Cequier, A., Garcia, E. J., Heras, M., Lopez-Sendon, J. L., Macaya, C., Azpitarte, J., Sanz, G., Chamorro, A., Lopez-Palop, R., Sionis, A., Aros, F., Garcia-Fernandez, E., Rubio, R., Hernandez, F., Tascon, J. C., Moreu, J., Betriu, A., Heras, M., Hernandez-Antolin, R., Fernandez-Ortiz, A., Moris, C., de Posada, I. S., Cequier, A., Esplugas, E., Melgares, R., Bosa, F., Garcia-Gonzalez, M. J., Lezaun, R., Carmona, J. R., Vazquez, J. M., Castro-Beiras, A., Picart, J. G., de Rozas, J. D., Fernandez, J. D., Vazquez, F. F., Alonso, N., Zueco, J. J., San Jose, J. M., San Roman, A., Hernandez, C., Garcia, J. M. H., Alcantara, A. G., Bethencourt, A., Fiol, M., Mancisidor, X., Mancisidor, X., Ruiz, R., Hidalgo, R., Sobrino, N., Maqueda, I. G., Torres, A., Aros, F., Amaro, A., & Jaquet, M.
Venue
European Heart Journal
Published
2010-10-22
Volume
32
Issue
1
Pages
51-60
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2118355238
Cited by
184
References
1
FWCI
6.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. https://app.cochat.ai/papers/10.1093/eurheartj/ehq375
The paper
Bueno, H., Betriu, A., Heras, M., Alonso, J. J., Cequier, A., Garcia, E. J., Lopez-Sendon, J. L., Macaya, C., Hernandez-Antolin, R., on behalf of the TRIANA Investigators, Bueno, H., Hernandez-Antolin, R., Alonso, J. J., Betriu, A., Cequier, A., Garcia, E. J., Heras, M., Lopez-Sendon, J. L., Macaya, C., . . . Jaquet, M. (2011). Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies. European Heart Journal. https://doi.org/10.1093/eurheartj/ehq375

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.